193 related articles for article (PubMed ID: 30339689)
1. Prevalence and risk factors of Occult Hepatitis C infections in blood donors from Mexico City.
Martínez-Rodríguez ML; Uribe-Noguez LA; Arroyo-Anduiza CI; Mata-Marin JA; Benitez-Arvizu G; Portillo-López ML; Ocaña-Mondragón A
PLoS One; 2018; 13(10):e0205659. PubMed ID: 30339689
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Occult Hepatitis C Virus Infection among Blood Donors in Jiangsu, China.
Lin H; Chen X; Zhu S; Mao P; Zhu S; Liu Y; Huang C; Sun J; Zhu J
Intervirology; 2016; 59(4):204-210. PubMed ID: 28208127
[TBL] [Abstract][Full Text] [Related]
3. Seronegative occult hepatitis C infection among hemodialysis patients: A prevalence study.
Mahmoudvand S; Shokri S; Azaran A; Seyedian SS; Makvandi M; Mirzaei H; Sheikhrobat SB
Ther Apher Dial; 2021 Apr; 25(2):218-224. PubMed ID: 32510846
[TBL] [Abstract][Full Text] [Related]
4. Occult hepatitis C virus infection among Egyptian hemodialysis patients.
Abdelrahim SS; Khairy R; Esmail MA; Ragab M; Abdel-Hamid M; Abdelwahab SF
J Med Virol; 2016 Aug; 88(8):1388-93. PubMed ID: 26743014
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of occult hepatitis C virus among hemodialysis patients in Tanta university hospitals: a single-center study.
Abdelmoemen G; Khodeir SA; Abou-Saif S; Kobtan A; Abd-Elsalam S
Environ Sci Pollut Res Int; 2018 Feb; 25(6):5459-5464. PubMed ID: 29214477
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of occult hepatitis C virus infection in the Iranian patients with human immunodeficiency virus infection.
Bokharaei-Salim F; Keyvani H; Esghaei M; Zare-Karizi S; Dermenaki-Farahani SS; Hesami-Zadeh K; Fakhim S
J Med Virol; 2016 Nov; 88(11):1960-6. PubMed ID: 27463051
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of occult hepatitis C virus infection in Iranian patients with beta thalassemia major.
Bastani MN; Bokharaei-Salim F; Keyvani H; Esghaei M; Monavari SH; Ebrahimi M; Garshasebi S; Fakhim S
Arch Virol; 2016 Jul; 161(7):1899-906. PubMed ID: 27132015
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of occult hepatitis C virus infection in beta-thalassemia major patients in Ahvaz, Iran.
Nasimzadeh S; Azaran A; Jalilian S; Makvandi M; Seyedian SS; Keikhaei B; Mehr FJ
Arch Virol; 2021 Oct; 166(10):2703-2710. PubMed ID: 34275067
[TBL] [Abstract][Full Text] [Related]
9. Detection of HCV genome in peripheral blood mononuclear cells of Iranian seropositive and HCV RNA negative in plasma of patients with beta-thalassemia major: Occult HCV infection.
Kahyesh-Esfandiary R; Sadigh ZA; Esghaei M; Bastani MN; Donyavi T; Najafi A; Fakhim A; Bokharaei-Salim F
J Med Virol; 2019 Jan; 91(1):107-114. PubMed ID: 30091793
[TBL] [Abstract][Full Text] [Related]
10. Occult Hepatitis C Virus Infection among Hemodialysis Patients: An Iranian Experience.
Taherpour S; Javanmard D; Ziaee M
Arch Iran Med; 2020 Sep; 23(9):586-592. PubMed ID: 32979904
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnosis of occult hepatitis C virus infection in Iranian injection drug users.
Sheikh M; Bokharaei-Salim F; Monavari SH; Ataei-Pirkooh A; Esghaei M; Moradi N; Babaei R; Fakhim A; Keyvani H
Arch Virol; 2019 Feb; 164(2):349-357. PubMed ID: 30390150
[TBL] [Abstract][Full Text] [Related]
12. Occult hepatitis C virus infection among haemodialysis patients.
Ali NK; Mohamed RR; Saleh BE; Alkady MM; Farag ES
Arab J Gastroenterol; 2018 Sep; 19(3):101-105. PubMed ID: 30245116
[TBL] [Abstract][Full Text] [Related]
13. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
[TBL] [Abstract][Full Text] [Related]
14. The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations.
Wang J; Liu J; Huang Y; Wright DJ; Li J; Zhou Z; He W; Yang T; Yao F; Zhu X; Wen G; Bi X; Tiemuer MH; Wen X; Huang M; Cao R; Yun Z; Lü Y; Ma H; Guo N; Yu Q; Ness P; Shan H;
Transfusion; 2013 Oct; 53(10 Pt 2):2489-97. PubMed ID: 23781978
[TBL] [Abstract][Full Text] [Related]
15. Occult hepatitis C virus infection in hemophilia patients and its correlation with interferon lambda 3 and 4 polymorphisms.
Nafari AH; Ayadi A; Noormohamadi Z; Sakhaee F; Vaziri F; Siadat SD; Fateh A
Infect Genet Evol; 2020 Apr; 79():104144. PubMed ID: 31838260
[TBL] [Abstract][Full Text] [Related]
16. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
[TBL] [Abstract][Full Text] [Related]
17. Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia.
Bernardin F; Tobler L; Walsh I; Williams JD; Busch M; Delwart E
Hepatology; 2008 May; 47(5):1446-52. PubMed ID: 18220272
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and follow-up of occult HCV infection in an Italian population free of clinically detectable infectious liver disease.
De Marco L; Manzini P; Trevisan M; Gillio-Tos A; Danielle F; Balloco C; Pizzi A; De Filippo E; D'Antico S; Violante B; Valfrè A; Curti F; Merletti F; Richiardi L
PLoS One; 2012; 7(8):e43541. PubMed ID: 22927986
[TBL] [Abstract][Full Text] [Related]
19. Understanding occult hepatitis C infection.
An T; Dean M; Flower R; Tatzenko T; Chan HT; Kiely P; Faddy HM
Transfusion; 2020 Sep; 60(9):2144-2152. PubMed ID: 33460181
[TBL] [Abstract][Full Text] [Related]
20. Detection of Hepatitis C virus RNA in peripheral blood mononuclear cells of patients with abnormal alanine transaminase in Ahvaz.
Makvandi M; Khalafkhany D; Rasti M; Neisi N; Omidvarinia A; Mirghaed AT; Masjedizadeh A; Shyesteh AA
Indian J Med Microbiol; 2014; 32(3):251-5. PubMed ID: 25008816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
